| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $89.8M | +25.7% |
| SG&A Expense | $37.4M | +27.4% |
| Operating Income | -$127.2M | -26.2% |
| Income Tax | $0 | — |
| Net Income | -$126.3M | -26.0% |
| EPS (Basic) | -$3.25 | -21.7% |
| EPS (Diluted) | -$3.25 | -21.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $61.1M | -61.7% |
| Current Assets | $64.0M | -61.7% |
| Total Assets | $107.4M | -49.8% |
| Current Liabilities | $15.1M | +5.8% |
| Total Liabilities | $46.6M | -7.6% |
| Stockholders' Equity | $60.8M | -62.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$93.9M | -13.7% |
| Capital Expenditures | $4.2M | +122.7% |
| Investing Cash Flow | -$4.2M | -103.4% |
| Financing Cash Flow | -$733K | -100.6% |
| Free Cash Flow | -$98.1M | -16.1% |